ATOS MEDICAL UK LIMITED
Get an alert when ATOS MEDICAL UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-06-30 (in 1mo)
Last filed for 2024-09-30
Confirmation statement due
2026-05-10
Overdue
Watchouts
Cash
—
Latest balance sheet
Net assets
£9M
+5.6% highest in 3 filed years
Employees
102
-1.9% vs 2023
Profit before tax
£5M
+20.6% highest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Confirmation statement overdue
Due 2026-05-10.
Net assets
5-year trend · vs Consumer Discretionary median
Accounts
5-year trend · latest reflected 2024-09-30
| Metric | Trend | 2022-01-01 | 2022-09-30 | 2022-10-01 | 2023-09-30 | 2024-09-30 |
|---|---|---|---|---|---|---|
| Turnover | — | £17,894,000 | — | £29,803,000 | £31,990,000 | |
| Operating profit | — | £960,000 | — | £3,818,000 | £4,517,000 | |
| Profit before tax | — | £960,000 | — | £3,840,000 | £4,632,000 | |
| Net profit | — | £758,000 | — | £3,006,000 | £3,440,000 | |
| Cash | — | — | — | — | — | |
| Total assets less current liabilities | — | £5,114,000 | — | £8,074,000 | £8,513,000 | |
| Net assets | — | £5,052,000 | — | £8,058,000 | £8,512,000 | |
| Equity | £4,294,000 | £5,052,000 | £5,052,000 | £8,058,000 | £8,512,000 | |
| Average employees | — | 86 | — | 104 | 102 | |
| Wages | — | £2,420,000 | — | £4,213,000 | £4,243,000 | |
| Directors' remuneration | — | £141,000 | — | £286,000 | £279,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-09-30 vs 2023-09-30
-
Turnover
+7.3%
£29,803,000 £31,990,000
highest in 3 filed years
-
Cash
—
Not reported
-
Net assets
+5.6%
£8,058,000 £8,512,000
highest in 3 filed years
-
Employees
-1.9%
104 102
-
Operating profit
+18.3%
£3,818,000 £4,517,000
highest in 3 filed years
-
Profit before tax
+20.6%
£3,840,000 £4,632,000
highest in 3 filed years
-
Wages
+0.7%
£4,213,000 £4,243,000
highest in 3 filed years
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2022-01-01 | 2022-09-30 | 2022-10-01 | 2023-09-30 | 2024-09-30 |
|---|---|---|---|---|---|---|
| Operating margin | — | 5.4% | — | 12.8% | 14.1% | |
| Net margin | — | 4.2% | — | 10.1% | 10.8% | |
| Return on capital employed | — | 18.8% | — | 47.3% | 53.1% | |
| Current ratio | — | — | — | 3.03x | 3.19x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- ATOS MEDICAL UK LIMITED 2021-03-10 → present
- COUNTRYWIDE SUPPLIES LIMITED 2001-04-26 → 2021-03-10
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Page Kirk LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Significant events
- “The Company continued to grow its Laryngectomy patient base across the United Kingdom, establishing itself as the leading provider in this field.”
- “The Company saw significant growth in its Tracheostomy patient base in the financial year... Whilst there was some disruption to supply of Tracheostomy Tubes into hospitals and other medical product distributors, the Company reported growth in its Tracheostomy Tubes.”
- “The current state of National Health Service (NHS) within the UK remains poor, there has been no significant impact on business performance. The Company continues to monitor changes in NHS policies and plans to ensure continuity of performance.”
- “There are currently several economic risks impacting both the World and UK economy. The on-going conflict in both Ukraine and the Middle East remains uncertain and continues to have global impact.”
- “The UK cost of living growth continues to put pressure on salaries.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 20 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CHAPUIS, Pascale | Director | 2022-03-07 | Aug 1970 | French |
| MIKKELSEN, Anton | Director | 2023-09-13 | May 1987 | Danish |
Show 20 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| STOCKLEY, Peter Darran | Secretary | 2001-04-27 | 2015-01-30 |
| WHITE ROSE FORMATIONS LIMITED | Corporate Nominee Secretary | 2001-04-26 | 2001-04-27 |
| BERTHELSEN, Ulrik | Director | 2018-10-29 | 2019-10-28 |
| BJERRE, Claus | Director | 2015-01-30 | 2018-10-29 |
| EICKHOFF, Philip Harald | Director | 2015-01-30 | 2019-08-28 |
| HANSVEDEN, John | Director | 2022-09-16 | 2023-05-03 |
| HUMPHREYS, Jennifer Ann | Director | 2005-05-04 | 2015-01-30 |
| HUMPHREYS, Peter James | Director | 2001-04-26 | 2005-05-04 |
| HUTTON, Stephanie, Finance & Operations Diector | Director | 2018-01-26 | 2018-07-13 |
| KNIGHT, Ashley | Director | 2022-09-15 | 2026-02-12 |
| KNIGHT, Ashley Alexander Julian | Director | 2020-03-25 | 2022-03-07 |
| LEIRE, Mattias | Director | 2015-01-30 | 2016-10-31 |
| MADSEN, Egil Molsted | Director | 2022-03-07 | 2022-09-15 |
| NICHOLL, James | Director | 2001-04-26 | 2005-05-04 |
| NICHOLL, Jennifer Mary | Director | 2005-05-04 | 2015-01-30 |
| RENSHAW, Jamie | Director | 2018-07-09 | 2022-03-07 |
| SKAK OLUFSEN, Christian | Director | 2022-03-07 | 2023-05-09 |
| STOCKLEY, Peter Darran | Director | 2001-04-26 | 2015-01-30 |
| VAN-AS BROOKS, Corina | Director | 2017-08-13 | 2020-03-31 |
| WALKER, Alastair James | Director | 2016-09-23 | 2018-01-15 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Niels Peter Louis-Hansen | Individual | Shares 25–50%, Voting 50–75%, Appoints directors | 2023-09-01 | Active |
| Atos Medical Ab | Corporate entity | Shares 75–100% | 2018-10-29 | Ceased 2018-10-29 |
| Atos Medical Ab | Corporate entity | Shares 75–100% | 2018-10-29 | Ceased 2018-10-29 |
| Atos Medical Ab | Corporate entity | Shares 75–100% | 2016-04-06 | Ceased 2018-10-29 |
Filing timeline
Last 20 of 122 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-30 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2026-04-30 | PSC09 | persons-with-significant-control | Withdrawal of a person with significant control statement | |
| 2026-04-30 | PSC08 | persons-with-significant-control | Notification of a person with significant control statement | |
| 2026-04-30 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2026-04-30 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2026-03-05 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-02 | AA | accounts | Accounts with accounts type full | |
| 2025-05-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-06-17 | AA | accounts | Accounts with accounts type full | |
| 2024-05-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-09 | AA | accounts | Accounts with accounts type full | |
| 2023-09-13 | AP01 | officers | Appoint person director company with name date | |
| 2023-05-09 | TM01 | officers | Termination director company with name termination date | |
| 2023-05-03 | TM01 | officers | Termination director company with name termination date | |
| 2023-05-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-29 | AP01 | officers | Appoint person director company with name date | |
| 2022-09-15 | AP01 | officers | Appoint person director company with name date | |
| 2022-09-15 | TM01 | officers | Termination director company with name termination date | |
| 2022-08-12 | AA | accounts | Accounts with accounts type full | |
| 2022-05-24 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 8
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.